The Philippines is the third-largest pharmaceutical market in ASEAN after Thailand and Indonesia. In 2019, total generic drug sales were PHP82.3 billion accounting for 63% of prescription sales and estimated to reach PHP110 Billion by 2024. The highest cost of medicines in the Philippines among ASEAN countries driving the purchase of more generic medicines than […]
Read More →Most errors and technical failures in clinical trials arise due to the improper selection of clinical trial designs. The clinical trial design selection will also have a strong impact on the cost and time associated with clinical trials. The expected outcomes shall be thoughtfully addressed while designing a clinical trial and the selection of clinical […]
Read More →Myanmar’s pharmaceutical market size was $456 million in 2017 with a percapita pharma expenditure of $8.5 and expected to reach $656 million in 2022. Myanmar’s economy is growing continuously, and the pharmaceutical industry is predicted to quickly grow into a $1.12 billion industry in the future. In Myanmar, both non-communicable diseases and communicable diseases are […]
Read More →Vietnam’s pharmaceutical market has grown significantly in the last two years by 10% to US$5.2 billion and estimated to reach US$6.6 billion this year. This expanding market growth contributes to the country’s per capita spending of US$85 billion for pharmaceuticals today. Reasons for pharmaceutical market growth Several reasons contribute to the pharmaceutical market growth in […]
Read More →Sourcing or importing the IMPs and their supportive products is a challenging process for many researchers and this is more prominent with the countries like Japan and China where understanding the regulatory is difficult due to the language barriers and rapid changing norms for making imports. Many key players in logistics are unclear about the […]
Read More →Getting the study drug at the right time is challenging for any clinical trial, and this is more prominent with multi-regional clinical trials. To have the IMPs and ancillaries at the clinical trial sites in time, the sponsors need to have the right people, processes, facilities, and technology in place. Generally, the sites require three […]
Read More →Japan is one of the world’s leading markets for cosmetic and personal care products. The Beauty and Personal Care Products Market is estimated to grow at a CAGR of 3.5% for the next five years in Japan. Along with this, Cosmetics shipments within Japan generated a market value of around 2.7 trillion Japanese yen in […]
Read More →As clinical trials have become increasingly global and complex, ancillaries have grown in volume, type, and expectations. The clinical trials supplies market is projected to reach USD 2.5 billion by 2025 owing to the logistics services with the increasing number of clinical trials involving temperature-sensitive drugs. Currently, North America is the largest market for clinical […]
Read More →Conduct of clinical trials is a demanding process. This requires not only the hiring of resources to perform various activities but also the material to support to actually execute different activities and processes. Some of these materials can be investigational products. But, a vast number of products could be non-investigational products required for the conduct […]
Read More →In the last 15 years, the Japanese nutraceutical industry such as dietary supplements and functional foods grew at an average rate of 15 percent per year. In 2019, Japan’s health-related food market was the third-largest in the world with an estimated value of $13.3 billion. In the last few decades, there is a growing appreciation […]
Read More →